<DOC>
	<DOCNO>NCT00352014</DOCNO>
	<brief_summary>The purpose study investigate whether level Platelet Inhibition assess five point-of-care platelet function assay correlate clinical ( periprocedural ) outcomes Acute Myocardial Infarction , death , Target Vessel revascularization and/or stroke patient undergo elective PCI .</brief_summary>
	<brief_title>Evaluation Comparison Several Point-of-Care Platelet Function Tests Predicting Clinical Outcomes Clopidogrel Pre-Treated Patients Undergoing Elective PCI .</brief_title>
	<detailed_description>Antiplatelet agents—aspirin , thienopyridines , platelet glycoprotein IIb/IIIa ( GpIIb/IIIa ) inhibitors—have become cornerstone treatment ischemic heart disease patient undergo percutaneous coronary intervention ( PCI ) 1,2 . However , several study demonstrate use platelet function assay subgroups patient receive either aspirin , clopidogrel , fail produce anticipated antiplatelet effect3-5 . Consequently , term like “ aspirin-resistance ” “ clopidogrel resistance ” introduce literature . Light transmittance platelet aggregometry generally consider gold standard determine platelet function , relevance vivo platelet function questionable logistically demand method make impossible use daily practice . In addition , aggregation one several important platelet function . The introduction several point-of-care assay may key widespread clinical use platelet function test identify call anti-platelet therapy low-responders . However , whether point-of-care platelet function test provide predictive value ( i.e . correlate clinical outcome ) allocation “ best ” suitable point-of-care Platelet function assay determine level inhibition platelet function remain establish .</detailed_description>
	<mesh_term>Angina Pectoris</mesh_term>
	<mesh_term>Angina , Stable</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Coronary artery disease objective evidence ischemia ( e.g. , symptoms angina pectoris , positive result stress test dynamic electrocardiographic [ ECG ] change ) Adequate Aspirin Clopidogrel pretreatment . ( Adequate clopidogrel pretreatment define 600 mg load dose clopidogrel least 6 hour prior PCIprocedure 300 mg load dose clopidogrel &gt; 24 hour prior PCIprocedure 75 mg dose clopidogrel least &gt; 5 day prior PCI procedure Patient think high likelihood require PCI ( significant angiographic lesion native coronary artery amenable require percutaneous coronary intervention ) A stent ( either drugeluting bare metal ) plan place least one lesion . Written Informed consent STsegment elevation Acute Myocardial Infarction ( STsegment ≥0.1mV ≥2 contiguous ECG lead persist least 20 minute ) within 48 hour symptom onset . Contraindications antithrombotic/antiplatelet therapy Failed coronary intervention previous 2 week Malignancies Increased risk bleeding ( previous stroke past month , active bleeding bleeding diathesis , recent trauma major surgery last month , suspect aortic dissection , oral anticoagulation therapy coumarin derivate within 7 day , recent use GPIIb/IIIa inhibitor within 14 day , severe uncontrolled hypertension &gt; 180 mmHg unresponsive therapy ) Relevant hematologic deviation ( hemoglobin &lt; 100g/L ( 6,2 mmol/L ) hematocrit &lt; 34 % , platelet count &lt; 100 x 109 /L platelet count &gt; 600 x 109/L ) Known allergy clopidogrel Pregnancy ( present suspect )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>Monitoring antiplatelet therapy</keyword>
	<keyword>antiplatelet therapy</keyword>
	<keyword>platelet function assay</keyword>
	<keyword>Aspirin</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>elective PCI</keyword>
</DOC>